Ascendis Pharma ADR (ASND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ASND | AZN | AMGN | GILD | VRTX |
| Company | Ascendis Pharma ADR | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 265.00 | 186.13 | 362.12 | 126.34 | 495.01 |
| High | 269.35 | 186.13 | 362.12 | 126.34 | 495.01 |
| Low | 262.76 | 186.13 | 362.12 | 126.34 | 495.01 |
| Latest | 266.72 | 186.13 | 362.12 | 126.34 | 495.01 |
| Change | +3.02 | -3.49 | unch | unch | -1.72 |
| % Change | +1.15% | -1.84% | unch | unch | -0.35% |
| Volume | 630,500 | 87,572 | 1,830 | 5,552 | 564 |
| 20-Day Average Volume | 945,770 | 1,928,704 | 3,118,562 | 9,071,527 | 1,801,188 |
| Previous Close | 263.70 | 189.62 | 362.12 | 126.34 | 496.73 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 229.95 | 181.95 | 349.37 | 126.02 | 460.94 |
| 20-Day Raw Stochastic | 92.41% | 71.39% | 97.33% | 48.20% | 89.41% |
| 20-Day Relative Strength | 67.08 | 51.73 | 60.55 | 45.83 | 67.26 |
| Weighted Alpha | +54.60 | +25.55 | +21.78 | +7.83 | +15.26 |
| Today's Opinion | 72% Buy | 8% Sell | 56% Buy | 72% Sell | 72% Buy |
| Previous Opinion | 72% Buy | 8% Buy | 56% Buy | 56% Sell | 72% Buy |
| Last Month's Opinion | 48% Buy | 40% Sell | 40% Sell | 24% Sell | 8% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +11.79% since 06/23/26 | +1.70% since 06/24/26 | +3.04% since 06/24/26 | +0.94% since 06/24/26 | +4.17% since 06/24/26 |
| Low | 235.51 on 06/25/26 | 184.28 on 06/26/26 | 350.06 on 06/25/26 | 123.67 on 06/25/26 | 473.50 on 06/25/26 |
| High | 271.89 on 06/25/26 | 191.13 on 06/29/26 | 363.11 on 06/29/26 | 128.86 on 06/29/26 | 503.89 on 06/26/26 |
| 1-Month | |||||
| %Chg | +19.01% since 05/29/26 | +3.57% since 06/01/26 | +10.02% since 06/01/26 | -3.63% since 06/01/26 | +12.91% since 06/01/26 |
| Low | 203.80 on 06/08/26 | 173.65 on 06/18/26 | 322.30 on 06/02/26 | 121.39 on 06/10/26 | 420.01 on 06/03/26 |
| High | 271.89 on 06/25/26 | 191.13 on 06/29/26 | 363.11 on 06/29/26 | 131.66 on 06/05/26 | 503.89 on 06/26/26 |
| 3-Month | |||||
| %Chg | +22.15% since 03/30/26 | -7.27% since 04/01/26 | +2.50% since 04/01/26 | -9.95% since 04/01/26 | +10.68% since 04/01/26 |
| Low | 203.80 on 06/08/26 | 173.65 on 06/18/26 | 320.52 on 05/05/26 | 121.39 on 06/10/26 | 412.27 on 05/05/26 |
| High | 271.89 on 06/25/26 | 207.30 on 04/10/26 | 363.11 on 06/29/26 | 142.97 on 04/09/26 | 503.89 on 06/26/26 |
| 6-Month | |||||
| %Chg | +27.41% since 12/30/25 | +1.23% since 12/31/25 | +10.64% since 12/31/25 | +2.93% since 12/31/25 | +9.19% since 12/31/25 |
| Low | 188.08 on 01/12/26 | 173.65 on 06/18/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 412.27 on 05/05/26 |
| High | 271.89 on 06/25/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 16,637,191 | 294,083,168 | 195,439,056 | 156,859,936 | 126,072,560 |
| Shares Outstanding, K | 62,377 | 1,550,908 | 539,708 | 1,241,570 | 253,805 |
| Annual Sales | 814,760,000 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -258,000,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 288,620,000 | 15,288,000,000 | 8,618,000,000 | 6,960,000,000 | 2,986,900,000 |
| Last Quarter Net Income | 736,580,000 | 3,080,000,000 | 1,819,000,000 | 2,021,000,000 | 1,031,400,000 |
| 60-Month Beta | 0.39 | 0.25 | 0.42 | 0.31 | 0.30 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.32 on 05/07/26 | 2.58 on 04/29/26 | 5.15 on 04/30/26 | 2.03 on 05/07/26 | 4.47 on 05/04/26 |
| Earnings Date | 08/06/26 | 07/27/26 | 08/04/26 | 08/06/26 | 08/03/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 05/15/26 | 0.820 on 06/15/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 06/15/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.62 | 16.31 | 15.09 | 29.71 |